IncobotulinumtoxinA
IncobotulinumtoxinA is a biological therapy with 17 clinical trials. Historical success rate of 71.4%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
8
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
71.4%
10 of 14 finished
28.6%
4 ended early
0
trials recruiting
17
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury
Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
Incobotulinum Toxin for the Treatment of Trigeminal Neuralgia
A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods
Longitudinal Evaluation and Real-world Evidence of NT201
Clinical Trials (17)
A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury
Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture
Incobotulinum Toxin for the Treatment of Trigeminal Neuralgia
A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods
Longitudinal Evaluation and Real-world Evidence of NT201
Xeomin Treatment of Glabellar Lines Using OLD Versus COLD
Botulinum Toxin A to Treat Arm Tremor
A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea
Effect of Video Game-assisted and BoNT-A Injection Therapy on Spasticity, Activity and Participation in CP Patients
Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot
The Treatment of Glabellar Frown Lines
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Tremor: A Customized Approach
IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Comparison of Escalating Doses of IncobotulinumtoxinA (Xeomin®) in the Treatment of Glabellar Rhytids
Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring
All 17 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 17